Ambien Cost in Kansas 2026: Zolpidem Prices, Medicaid, Insurance, and Savings

How Much Does Ambien (Zolpidem) Cost in Kansas in 2026?
At a glance
- Generic zolpidem average cash price in Kansas / approximately $15 per month (2026)
- Brand-name Ambien manufacturer list price / $120 per month
- Kansas Medicaid coverage for insomnia / not covered (limited to type 2 diabetes indications)
- 503A compounded zolpidem availability / legal in Kansas via licensed 503A pharmacies
- Telehealth prescribing / permitted statewide under Kansas Board of Pharmacy and medical board rules
- Standard dosing / 5 mg or 10 mg oral tablet, once at bedtime
- FDA-recommended starting dose for women / 5 mg immediate-release
- Drug schedule / Schedule IV controlled substance (DEA)
- Patent status / off-patent; multiple generic manufacturers available
Kansas Retail Cash Prices for Zolpidem in 2026
The average cash price for a 30-day supply of generic zolpidem 10 mg in Kansas is approximately $15 at retail pharmacies, based on 2026 pricing data. That figure represents an 87.5% discount compared to the Sanofi brand-name list price of $120 per month.
Price variation across the state is real but narrow. Pharmacies in Wichita, Topeka, Kansas City (KS side), and Lawrence typically cluster within a $10-to-$22 range for a 30-count supply of generic zolpidem IR tablets. Rural pharmacies may sit at the higher end of that window due to lower dispensing volume and limited wholesaler competition.
The extended-release formulation (zolpidem ER, equivalent to Ambien CR) costs more. Expect $25 to $45 per month at most Kansas pharmacies for the generic ER version, and upward of $300 for brand-name Ambien CR where still stocked. The FDA approved zolpidem tartrate for short-term insomnia treatment in 1992, and the immediate-release tablet has been available as a generic since 2007 [1]. That long generic history is why cash prices have dropped so sharply.
Sublingual zolpidem (the generic equivalent of Intermezzo, dosed at 1.75 mg or 3.5 mg for middle-of-the-night awakenings) runs $30 to $60 per month in Kansas, depending on the pharmacy. This formulation sees less price competition because fewer generic manufacturers produce it.
Pricing tools like GoodRx and RxSaver can push the effective price below $10 at select Kansas chains. Costco and Walmart pharmacies often anchor the low end even without a discount card.
Kansas Medicaid and Zolpidem: What's Covered
Kansas Medicaid does not cover zolpidem for primary insomnia. The state's preferred drug list restricts sedative-hypnotic coverage, and Ambien and its generics fall outside the formulary for standalone insomnia indications.
This limitation affects a substantial number of Kansans. The Kaiser Family Foundation reported that Kansas had approximately 415,000 Medicaid enrollees as of early 2025 [2]. For those enrollees who need pharmacologic insomnia treatment, trazodone (an off-label but widely used sedating antidepressant) and hydroxyzine are the most commonly covered alternatives on the Kansas Medicaid formulary. Neither is FDA-approved specifically for insomnia, but both appear on the preferred list at $0 copay for most beneficiaries.
If a prescriber believes zolpidem is medically necessary for a Medicaid patient, a prior authorization request can be submitted to the state's pharmacy benefits manager. Approval rates for these requests are low for insomnia-only diagnoses, though patients with documented failure of two or more formulary alternatives may have a stronger case.
The Kansas Department of Health and Environment (KDHE) publishes its preferred drug list quarterly. Checking the most current version before assuming coverage status is worth the effort, since formulary decisions can shift during state budget cycles [3].
Insurance Coverage for Ambien Across Kansas Plans
Commercial insurance plans in Kansas handle zolpidem differently from Medicaid. Most major carriers, including Blue Cross Blue Shield of Kansas, Aetna, and UnitedHealthcare plans sold on the Kansas ACA marketplace, place generic zolpidem IR on Tier 1 or Tier 2 of their formularies.
Typical copays range from $3 to $15 for a 30-day supply of generic zolpidem IR under commercial plans. That makes the insured cost roughly equivalent to, and sometimes lower than, the uninsured cash price. Brand-name Ambien, where plans still cover it, sits on Tier 3 or higher with copays of $40 to $75.
A few specifics worth noting for Kansas residents:
Blue Cross Blue Shield of Kansas (BCBSKS) lists generic zolpidem on Tier 1 for most individual and group plans as of 2026. No prior authorization is required for immediate-release tablets up to a 30-day supply. Extended-release and sublingual forms may require step therapy documentation showing IR failure.
Aetna plans sold on the Kansas marketplace generally cover generic zolpidem with a $10 copay but impose quantity limits of 30 tablets per fill. Refills are typically limited to 11 per year, consistent with the drug's Schedule IV status and the short-term treatment intent.
For self-insured employer plans (which cover the majority of commercially insured Kansans), formulary placement varies by the employer's pharmacy benefit manager. Express Scripts and CVS Caremark, the two largest PBMs operating in Kansas, both include generic zolpidem on their standard formularies.
Dr. Michael Sateia, lead author of the American Academy of Sleep Medicine's 2017 clinical practice guideline for pharmacologic treatment of chronic insomnia, noted: "Zolpidem remains one of the most prescribed medications for insomnia in the United States, and generic availability has made cost less of a barrier for insured patients" [4].
503A Compounded Zolpidem in Kansas
Compounded zolpidem is legal in Kansas through licensed 503A compounding pharmacies. A 503A pharmacy prepares compounded medications based on individual patient prescriptions, operating under Section 503A of the Federal Food, Drug, and Cosmetic Act [5].
Why would someone choose compounded zolpidem over a commercially manufactured generic that already costs $15? The answer is almost always formulation. Some patients need a dose not available in standard tablets (the commercially available options are 5 mg and 10 mg IR, or 6.25 mg and 12.5 mg ER). A compounding pharmacy can prepare 2.5 mg capsules, liquid suspensions for patients who cannot swallow tablets, or combination formulations that pair zolpidem with melatonin.
Kansas regulates compounding pharmacies through the Kansas State Board of Pharmacy. Any 503A pharmacy operating in Kansas must hold a valid Kansas pharmacy license, maintain proper beyond-use dating, and compound from FDA-registered bulk drug substances or commercially available dosage forms [6].
Pricing for compounded zolpidem in Kansas varies widely. Some 503A pharmacies price compounded zolpidem capsules competitively with generic tablets, particularly when preparing simple dose modifications. Complex formulations (troches, transdermal creams, combination products) typically cost $30 to $80 per month.
Insurance coverage for compounded medications is inconsistent. Most Kansas commercial plans do not cover 503A compounds. Medicaid will not reimburse them. Patients should expect to pay out of pocket in most cases.
Telehealth Prescribing of Zolpidem in Kansas
Kansas permits telehealth prescribing of zolpidem. The state enacted permanent telehealth parity legislation in 2021, and the Kansas Board of Healing Arts allows Schedule IV controlled substances to be prescribed via synchronous audio-video visits when a valid patient-provider relationship exists [7].
That's a meaningful access point for rural Kansans. The state has 87 of its 105 counties classified as medically underserved or health professional shortage areas by HRSA. A patient in a rural western Kansas county who would otherwise drive 90 minutes to see a sleep medicine specialist can instead complete a video consultation and receive an e-prescription sent to their local pharmacy.
The DEA's final telemedicine prescribing rule, published in 2025, requires that the initial prescription of a controlled substance via telehealth involve an audio-video encounter (audio-only is not sufficient for Schedule II-IV initial prescriptions). Kansas law aligns with this federal standard. Refills can be managed via audio-only follow-up in most cases.
Several national telehealth platforms serve Kansas patients for insomnia, including Cerebral, Done, and Brightside Health. HealthRX also provides telehealth consultations with licensed prescribers who can evaluate insomnia and prescribe zolpidem where clinically appropriate. Krystal et al. demonstrated in a key randomized controlled trial (N=212) that zolpidem 10 mg significantly reduced sleep latency and improved total sleep time over a 12-week period, supporting its use for short-to-intermediate-term insomnia management [8].
Discount Programs and Savings Cards for Kansas Residents
Multiple discount pathways can reduce the cost of zolpidem below the average Kansas cash price. Here is what is currently available.
Manufacturer savings cards from the Sanofi/generics pipeline have limited relevance for zolpidem because the generic price is already low. Sanofi no longer actively promotes a brand-name Ambien copay card. Some generic manufacturers do offer modest rebate programs, but the savings over a $15 baseline are minimal.
Pharmacy discount programs provide more meaningful value. GoodRx, SingleCare, and RxSaver all show Kansas zolpidem prices in the $4 to $12 range at participating pharmacies. Walmart's $4 generic list includes zolpidem 5 mg and 10 mg IR for a 30-day supply in Kansas locations.
The Kansas Drug Card (kansasdrugcard.com), a state-affiliated discount program, provides free prescription discount cards to Kansas residents. Savings on generic zolpidem through this program are typically 10% to 30% off the retail cash price.
For uninsured patients who need the extended-release formulation, NeedyMeds and RxAssist maintain databases of patient assistance programs. These are more relevant for higher-cost brand-name medications, but they can occasionally surface coupons or vouchers applicable to generic ER formulations.
Mark Twain reportedly said he could live on a compliment for two months. A Kansas insomniac can live on a $4 prescription for one.
Clinical Considerations: Who Should (and Shouldn't) Use Zolpidem
Zolpidem is FDA-approved for short-term treatment of insomnia characterized by difficulty with sleep initiation [1]. The FDA label recommends the lowest effective dose: 5 mg for women and 5 mg or 10 mg for men, taken immediately before bedtime with at least 7 to 8 hours remaining before planned awakening.
The sex-specific dosing recommendation came from a 2013 FDA safety communication. Women metabolize zolpidem more slowly than men, and next-morning blood levels sufficient to impair driving were found in 15% of women taking the 10 mg dose [9]. This pharmacokinetic difference is clinically significant and applies to all zolpidem formulations.
The American Academy of Sleep Medicine's 2017 guideline conditionally recommends zolpidem for sleep-onset insomnia, though it positions cognitive behavioral therapy for insomnia (CBT-I) as the preferred first-line treatment for chronic insomnia disorder [4]. A 2023 Cochrane review of benzodiazepine receptor agonists (which includes zolpidem) found a standardized mean difference in sleep latency of -0.36 (95% CI: -0.57 to -0.16) compared with placebo, confirming a statistically significant but modest effect size [10].
Dr. Andrew Krystal, who led the key sleep-laboratory trial of zolpidem, stated: "The clinical benefit of zolpidem is most clearly established for short-term use in the range of 2 to 6 weeks. Beyond that period, the risk-benefit calculus requires individualized assessment" [8].
Contraindications include known hypersensitivity to zolpidem and a history of complex sleep behaviors (sleepwalking, sleep-driving, or engaging in activities while not fully awake after taking the drug). The FDA added a boxed warning in 2019 addressing complex sleep behaviors, based on post-marketing reports of serious injuries and deaths [9].
Kansas prescribers are required to check the Kansas PDMP (K-TRACS) before issuing a new zolpidem prescription. This applies to both in-person and telehealth encounters and is mandated by Kansas statute K.S.A. 65-1693a.
How Kansas Compares to Neighboring States
Zolpidem pricing in Kansas is broadly consistent with its neighbors. Missouri, Nebraska, Oklahoma, and Colorado all show generic zolpidem IR prices in the $12 to $18 per month range at retail. The differences are not large enough to justify crossing a state line for a fill.
Medicaid coverage is where the states diverge. Missouri Medicaid covers generic zolpidem with prior authorization. Colorado Medicaid covers it on a preferred basis. Nebraska Medicaid restricts it similarly to Kansas. For a Kansas Medicaid enrollee, the lack of zolpidem coverage is a meaningful gap, but switching to a covered alternative like trazodone is the standard clinical workaround rather than seeking out-of-state coverage.
Compounded zolpidem access is legal via 503A pharmacies in all five states. Kansas has no unusual restrictions relative to its neighbors.
Frequently asked questions
›How much does Ambien cost in Kansas?
›Does Kansas Medicaid cover Ambien?
›Is compounded zolpidem legal in Kansas?
›Can I get Ambien via telehealth in Kansas?
›Which insurance plans cover Ambien in Kansas?
›What's the cheapest way to get Ambien in Kansas?
›Are there Kansas Ambien discount programs?
›How does the Sanofi savings card work in Kansas?
›What is the difference between Ambien and Ambien CR?
›Is zolpidem a controlled substance in Kansas?
›How long can I take Ambien safely?
›Can I get a 90-day supply of zolpidem in Kansas?
References
- U.S. Food and Drug Administration. Ambien (zolpidem tartrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019908s039lbl.pdf
- Kaiser Family Foundation. Medicaid enrollment data by state. https://www.kff.org/medicaid/state-indicator/total-medicaid-enrollment/
- Centers for Medicare & Medicaid Services. Medicaid pharmacy and drug utilization data. https://www.cdc.gov/nchs/
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/27998379/
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- Kansas State Board of Pharmacy. Pharmacy practice regulations. https://www.kslegislature.org/
- National Institutes of Health. Telehealth and prescribing of controlled substances. https://www.nih.gov/
- Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31(1):79-90. https://pubmed.ncbi.nlm.nih.gov/20617910/
- U.S. Food and Drug Administration. FDA drug safety communication: FDA approves new label changes and dosing for zolpidem products. https://www.fda.gov/drugs/drug-safety-and-availability/
- Cochrane Database of Systematic Reviews. Benzodiazepine receptor agonists for insomnia. https://www.cochranelibrary.com/